经鼻泪道扩张联合丝裂霉素C治疗鼻泪管阻塞  

Nasolacrimal duct dilating with mitomycin C for nasolacrimal duct obstruction

作　　者：秦民安[1] 冯梅艳[1] 

机构地区：[1]枣庄市立医院眼科,山东枣庄277102

出　　处：《山东大学耳鼻喉眼学报》2009年第3期48-49,共2页Journal of Otolaryngology and Ophthalmology of Shandong University

摘　　要：目的评价经鼻泪道扩张联合丝裂霉素C(MMC)治疗鼻泪管阻塞的疗效和临床应用价值。方法将60例鼻泪管阻塞患者随机分为丝裂霉素组(A组)和硅胶管组(B组),经鼻泪道扩张后A组局部使用MMC,B组逆行置入硅胶管,随访6个月,观察治疗成功率。结果经鼻泪道扩张联合MMC与逆行置入硅胶管术的疗效差异无统计学意义(P=0.058)。结论经鼻泪道扩张联合MMC治疗鼻泪管阻塞可取得与逆行置入硅胶管术相似的临床疗效,具有操作简便、费用低廉、治疗时间短、创伤小、恢复快等优点。Objective To investigate the efficacy and practicability of through nasolacrimal duct dilating with mitomycin C in treatment of nasolacrimal duct obstruction. Methods 60 patients were randomly divided into two groups： Group A received mitomycin C and Group B received a silicone stent. After nasolacrimal duct dilating, mitomycin C was used in Group A, and a silicone stent was retrogradely placed in Group B. Results Followed up for 6 months, efficacy of the two groups was not significantly different through a Chi square test. Conclusion Nasolacrimal duct dilating with mitomycin C has similar clinical efficacy with retrograde placement of a silicone stent. It has many advantages, such as simple operation, cheap charge, short treatment-time, small trauma, and quick resumption.

关 键 词：鼻泪管阻塞 泪道探通 丝裂霉素C 逆行置管术 

分 类 号：R766.33[医药卫生—耳鼻咽喉科]